These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 21494805)

  • 1. In vivo imaging analysis of the interaction between unusually large von Willebrand factor multimers and platelets on the surface of vascular wall.
    Rybaltowski M; Suzuki Y; Mogami H; Chlebinska I; Brzoska T; Tanaka A; Banno F; Miyata T; Urano T
    Pflugers Arch; 2011 Jun; 461(6):623-33. PubMed ID: 21494805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombospondin-1 controls vascular platelet recruitment and thrombus adherence in mice by protecting (sub)endothelial VWF from cleavage by ADAMTS13.
    Bonnefoy A; Daenens K; Feys HB; De Vos R; Vandervoort P; Vermylen J; Lawler J; Hoylaerts MF
    Blood; 2006 Feb; 107(3):955-64. PubMed ID: 16204318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carboxyl terminus of ADAMTS13 directly inhibits platelet aggregation and ultra large von Willebrand factor string formation under flow in a free-thiol-dependent manner.
    Bao J; Xiao J; Mao Y; Zheng XL
    Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):397-407. PubMed ID: 24357063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ADAMTS-13 metalloprotease interacts with the endothelial cell-derived ultra-large von Willebrand factor.
    Dong JF; Moake JL; Bernardo A; Fujikawa K; Ball C; Nolasco L; López JA; Cruz MA
    J Biol Chem; 2003 Aug; 278(32):29633-9. PubMed ID: 12775718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ADAMTS-13 rapidly cleaves newly secreted ultralarge von Willebrand factor multimers on the endothelial surface under flowing conditions.
    Dong JF; Moake JL; Nolasco L; Bernardo A; Arceneaux W; Shrimpton CN; Schade AJ; McIntire LV; Fujikawa K; López JA
    Blood; 2002 Dec; 100(12):4033-9. PubMed ID: 12393397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. P-selectin anchors newly released ultralarge von Willebrand factor multimers to the endothelial cell surface.
    Padilla A; Moake JL; Bernardo A; Ball C; Wang Y; Arya M; Nolasco L; Turner N; Berndt MC; Anvari B; López JA; Dong JF
    Blood; 2004 Mar; 103(6):2150-6. PubMed ID: 14630802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unwinding the von Willebrand factor strings puzzle.
    De Ceunynck K; De Meyer SF; Vanhoorelbeke K
    Blood; 2013 Jan; 121(2):270-7. PubMed ID: 23093621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formation of platelet strings and microthrombi in the presence of ADAMTS-13 inhibitor does not require P-selectin or beta3 integrin.
    Chauhan AK; Goerge T; Schneider SW; Wagner DD
    J Thromb Haemost; 2007 Mar; 5(3):583-9. PubMed ID: 17166247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in von Willebrand factor-cleaving protease (ADAMTS13) activity after infusion of desmopressin.
    Reiter RA; Knöbl P; Varadi K; Turecek PL
    Blood; 2003 Feb; 101(3):946-8. PubMed ID: 12393734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelial CD40 Mediates Microvascular von Willebrand Factor-Dependent Platelet Adhesion Inducing Inflammatory Venothrombosis in ADAMTS13 Knockout Mice.
    Tahir S; Wagner AH; Dietzel S; Mannell H; Pircher J; Weckbach LT; Hecker M; Pohl U
    Thromb Haemost; 2020 Mar; 120(3):466-476. PubMed ID: 32135568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic antithrombotic effects of ADAMTS13.
    Chauhan AK; Motto DG; Lamb CB; Bergmeier W; Dockal M; Plaimauer B; Scheiflinger F; Ginsburg D; Wagner DD
    J Exp Med; 2006 Mar; 203(3):767-76. PubMed ID: 16533881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single particle tracking of ADAMTS13 (a disintegrin and metalloprotease with thrombospondin type-1 repeats) molecules on endothelial von Willebrand factor strings.
    De Ceunynck K; Rocha S; De Meyer SF; Sadler JE; Uji-i H; Deckmyn H; Hofkens J; Vanhoorelbeke K
    J Biol Chem; 2014 Mar; 289(13):8903-15. PubMed ID: 24550384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma Peptidylarginine Deiminase IV Promotes VWF-Platelet String Formation and Accelerates Thrombosis After Vessel Injury.
    Sorvillo N; Mizurini DM; Coxon C; Martinod K; Tilvawala R; Cherpokova D; Salinger AJ; Seward RJ; Staudinger C; Weerapana E; Shapiro NI; Costello CE; Thompson PR; Wagner DD
    Circ Res; 2019 Aug; 125(5):507-519. PubMed ID: 31248335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of a mouse model to elucidate the phenotypic effects of the von Willebrand factor cleavage mutants, Y1605A/M1606A and R1597W.
    Pruss CM; Golder M; Bryant A; Hegadorn C; Haberichter S; Lillicrap D
    J Thromb Haemost; 2012 May; 10(5):940-50. PubMed ID: 22372972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemolytic uremic syndrome-associated Shiga toxins promote endothelial-cell secretion and impair ADAMTS13 cleavage of unusually large von Willebrand factor multimers.
    Nolasco LH; Turner NA; Bernardo A; Tao Z; Cleary TG; Dong JF; Moake JL
    Blood; 2005 Dec; 106(13):4199-209. PubMed ID: 16131569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of CD40 and ADAMTS13 in von Willebrand factor-mediated endothelial cell-platelet-monocyte interaction.
    Popa M; Tahir S; Elrod J; Kim SH; Leuschner F; Kessler T; Bugert P; Pohl U; Wagner AH; Hecker M
    Proc Natl Acad Sci U S A; 2018 Jun; 115(24):E5556-E5565. PubMed ID: 29793936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Numerical study of ultra-large von Willebrand factor multimers in coagulopathy.
    Rahmati N; Keshavarz Motamed P; Maftoon N
    Biomech Model Mechanobiol; 2024 Jun; 23(3):737-756. PubMed ID: 38217745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unraveling the scissile bond: how ADAMTS13 recognizes and cleaves von Willebrand factor.
    Crawley JT; de Groot R; Xiang Y; Luken BM; Lane DA
    Blood; 2011 Sep; 118(12):3212-21. PubMed ID: 21715306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutation and ADAMTS13-dependent modulation of disease severity in a mouse model for von Willebrand disease type 2B.
    Rayes J; Hollestelle MJ; Legendre P; Marx I; de Groot PG; Christophe OD; Lenting PJ; Denis CV
    Blood; 2010 Jun; 115(23):4870-7. PubMed ID: 20200350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble plasma-derived von Willebrand factor assembles to a haemostatically active filamentous network.
    Barg A; Ossig R; Goerge T; Schneider MF; Schillers H; Oberleithner H; Schneider SW
    Thromb Haemost; 2007 Apr; 97(4):514-26. PubMed ID: 17393012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.